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When Desperate Patients Go to Court for Unproven Treatments
— The Battle for Hospital Independence
Christopher Robertson, J.D., Ph.D., and Margaret Houtz, B.S.

A

s the Covid-19 pandemic
wears on, patients have asked
courts to compel hospitals to administer unproven therapies, with
mixed legal results. Although talk
radio hosts, politicians, and social media users have promoted
various treatment approaches, they
have given particular attention to
ivermectin. The Food and Drug
Administration (FDA) has approved ivermectin for use in humans for treating onchocerciasis
(river blindness), intestinal strongyloidiasis, certain other parasitic worms, head lice, and skin conditions such as rosacea. Although
this approval facilitates legal offlabel use for prophylaxis against
or treatment of other conditions,
both the FDA and the Centers for
Disease Control and Prevention
have cautioned against using ivermectin for Covid-19, citing adverse gastrointestinal and neurologic effects. In addition, a
Cochrane review concluded that
“overall, the reliable evidence
available does not support the
use of ivermectin for treatment
or prevention of COVID-19 outside of well-designed randomized
trials.”1
In U.S. hospitals, requests for
ivermectin to treat Covid-19 have
generally come as last-ditch efforts by family members of critically sick patients. For example,
Jason Jones, a patient in Texas,
was on a ventilator and in a medically induced coma for weeks
before his wife requested that
ivermectin be administered (see
table). When the hospital didn’t
provide the medication, Jones’
wife found an unaffiliated doctor

1200

who was willing to prescribe it
and brought a court challenge
seeking to compel the hospital to
administer it. She ultimately lost,
but several other patients and
surrogates have prevailed in similar suits among the hundreds
filed nationwide, according to
media reports.
Because these cases are often
filed in local courts on an emergency basis and few have been
appealed, extensive court records
aren’t always created. In three
cases for which legal dockets are
available — from Illinois, Ohio,
and the Jones case in Texas —
the lower court granted the
plaintiffs’ requests for ivermectin.
In the Ohio case, however, the
court refused to issue continued
injunctive relief after a 14-day
period, and in the Texas case, an
appeals court overturned the trial
court’s decision. In three other
cases — from Delaware, Michigan, and New York — trial courts
refused the plaintiffs’ requests.
In the Michigan case, the decision was upheld on appeal.
This wave of litigation has its
roots in legal frameworks related to prescribing medication, the
doctor–patient relationship, physician licensing, and hospitalcredentialing procedures. Although
state laws are fairly consistent,
these frameworks are pliable
enough that various judges have
decided differently on the same
issue. As the court in Michigan
wrote, the question is “whether
the judiciary has the legal authority to compel a hospital to
administer a drug, on an off-label
use, that the hospital considers
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may harm its patient, and where
that use is not sanctioned by the
FDA and other health authorities.” However, these lawsuits
have also called into question the
judiciary’s role in medical decision making.
According to common law, establishing a doctor–patient relationship is typically voluntary for
both parties. Once this relationship is formed, doctors have a
duty to use their medical judgment to provide competent care
and may face discipline or liability for providing substandard care.
Physicians have no obligation to
provide futile or harmful care;
requiring them to do so could
cause moral distress.2 The provision of futile care can also affect
the interests of other patients,
even outside the pandemic context of extreme scarcity.3
Doctor–patient relationships
aren’t exclusive, however — patients can establish relationships
with several doctors, and they
aren’t confined to a particular
hospital when seeking new medical advice. In the recent ivermectin cases, patients who were stymied by their treating hospitals
sought out other doctors to prescribe the medication, including
doctors who have become notorious specifically for their willingness to provide this service.
In tension with this philosophy of patients’ choice regarding
their physicians, hospital bylaws
determine the membership of the
medical staff and thus who can
order medication within the hospital. This system is a function of
hospital-accreditation standards,
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Selected U.S. Court Cases in Which Patients Sought Access to Ivermectin in Hospitals.
Case and State

Outcome

Rationale

DeMarco v. Christiana Care Hospital won; the court didn’t compel the
hospital to administer ivermectin.
Health Services, Inc.,
Delaware

Patients, even gravely ill ones, don’t have a right to a
particular treatment.

Frey v. Trinity HealthMichigan, Michigan

Hospital won; the court didn’t compel the
hospital to comply with an unaffiliated
physician’s ivermectin prescription.

Texas Health Huguley, Inc.
v. Jones, Texas

Hospital lost originally, then won; the lower The appeals court emphasized that “judges are not
court required the hospital to give the
doctors.” The court is “not empowered to decide
prescribing physician emergency ICU
whether a particular medication should be admin
privileges to administer ivermectin; on
istered, or whether a particular doctor should be
appeal, the court didn’t force the hospi
granted ICU privileges.”
tal to allow administration of ivermectin
within the hospital.

Smith v. West Chester
Hospital, LLC, Ohio

Hospital lost originally, then won; the court
initially ordered the hospital to adminis
ter ivermectin for 14 days; later, the
court denied the patient’s request for
continued ivermectin treatment.

There is no strong scientific evidence that ivermectin
is effective; the patient could be transferred to an
other hospital; and public policy doesn’t allow “a
physician to try ‘any’ type of treatment on human
beings.”

D.J.C. v. Staten Island
University HospitalNorthwell Health,
New York

Hospital won; the court didn’t compel the
hospital to administer ivermectin pre
scribed by a third-party physician.

The patient didn’t submit any evidence that ivermectin
is an effective or approved treatment for Covid-19.
The patient also failed to show that irreparable
harm would occur without the legal remedy.

Ng v. Edward-Elmhurst
Healthcare, Illinois

Patient won; the court compelled the hospi
tal to grant a third-party physician privi
leges to administer ivermectin.

There is no situation more extraordinary than when a
person’s life is hanging in the balance.

which are required by payers, including Medicare. As courts have
recognized, although the practice
of medicine is the responsibility
of licensed physicians, hospitals
are also bound by an independent legal duty to patients. This
duty requires hospitals “to use
reasonable care in formulating
the policies and procedures that
govern its medical staff and nonphysician personnel, to exercise
reasonable care in the selection
of its medical staff, and to periodically monitor and review the
medical staff’s competence.”4
Traditionally, there have been
two workarounds for resolving
conflicts between patient choice
and hospital independence. First,
physicians who have hospital privileges can exercise their own

A court ordering a hospital to do something (i.e., an in
junction) is an “extraordinary” action. Although the
court has sympathy for the ill patient, the court lim
ited its analysis to whether the patient met the crite
ria for an injunction. The court held that the patient
did not, because, among other considerations, the
patient didn’t show that irreparable harm would oc
cur if ivermectin wasn’t administered.

judgment to confirm an outside
doctor’s prescription and order
medication for a hospitalized patient. Second, when a hospital refuses to provide certain care, the
patient can be transferred to a
different hospital. In the ivermectin cases, apparently no hospital
physician was willing to prescribe the drug and transfer
was infeasible, because of either
patient-related risks or the lack
of a physician with privileges at a
hospital that was willing to accept the transfer.
When the quandary has remained, several courts have sided
with hospitals. The judges in these
cases haven’t focused on the
medical issue of whether ivermectin would or wouldn’t be
safe and effective for treating
n engl j med 386;13

nejm.org

Covid-19 — a question that they
aren’t competent to answer, especially in the setting of an emergency petition with no opportunity for robust fact-finding. Instead,
these courts have focused on
whether the judiciary has the
authority to issue an injunction
compelling a hospital to act contrary to its staff’s judgment. As
the court in Texas wrote, “It
would be illogical to impose a
duty to use reasonable care upon
a hospital, but to deprive the
hospital of the ability to implement policies and programs that
it deems reasonable.”
In other cases, trial courts
have taken the opposite tack. Arguing that because petitioning
patients are near death, and therefore there is little downside to

March 31, 2022

The New England Journal of Medicine
Downloaded from nejm.org at BOSTON UNIVERSITY on May 24, 2022. For personal use only. No other uses without permission.
Copyright © 2022 Massachusetts Medical Society. All rights reserved.

1201

When Patients Go to Court for Unproven Treatments

PERS PE C T IV E

administering ivermectin, some
judges have ordered hospitals to
grant prescribing doctors emergency privileges. In the Illinois
case, for example, the judge stated, “I can’t think of a more extraordinary situation than when
we are talking about a man’s
life.” Yet of course having lives at
stake isn’t exceptional in hospitals, and it is all the more reason
to ensure that practice is evidence based. Although a hospital
granting emergency privileges is
arguably a fine outcome for an
individual patient — if treatment
with ivermectin reflects the patient’s or a surrogate’s informed
choice and the advice of a competent physician — such an ad
hoc approach undermines the
policy of having inAn audio interview
dependent medical
with Prof. Robertson
staff oversee the qual
is available at NEJM.org
ity of care in U.S.
hospitals. According to this view,
hospitals aren’t accountable institutions, just places where health
care happens, for better or worse.
Although these decisions may

make it seem as if judges are elevating themselves above doctors
and hospitals, the judges might
see themselves as merely resolving a dispute between two physicians: one in the hospital, opposed to ivermectin’s use, and
the other outside the hospital,
supporting its use. In this case,
the tie goes to the patient’s (or
surrogate’s) preference. But this
conflict invites the larger question of why a small minority of
physicians should be allowed to
promote themselves as practicing
in ways not supported by evidence.
In one sense, these court battles are mere echoes of previous
controversies involving patients
who have demanded treatments
that hospitals considered futile
or hospitals that wouldn’t perform abortions or provide drugs
intended to hasten death. However, the present moment represents the strange intersection of
a deadly pandemic, the rise of
social media sites where treatments are promoted directly to

patients, and a decade in which
the “right to try” unapproved
treatments has been supported by
legislatures, Congress, and the
White House.5 The ground may
be shifting, but at the moment,
courts are preserving the institutional integrity of both health
care and the judiciary.
Disclosure forms provided by the authors
are available at NEJM.org.
From Boston University School of Law, Boston.
This article was published on March 9, 2022,
at NEJM.org.
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“The Sombre Aspect of the Entire Landscape” — Epidemiology
and the Faroe Islands
Perri Klass, M.D., and Adam J. Ratner, M.D.

I

n December 2021, as the impact of the omicron variant of
SARS-CoV-2 began to be felt,
commentators reached for a comparison to clarify the increased
infectiousness of this new variant, which would occasion renewed debate about holiday shutdowns and overwhelmed health
systems. Everyone from former
Centers for Disease Control and
Prevention director Tom Frieden
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to television news anchors began
comparing omicron to the most
contagious virus we know:
measles. In January 2021, we had
drawn a different analogy to measles to argue for vaccinating children against Covid-19 to protect
both them and their communities.1 These newer discussions
focused on contagion, the area
in which measles is unmatched.
On December 23, amid the

n engl j med 386;13
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flurry of reports trying to elucidate omicron’s peculiarities, a preprint appeared: “Omicron Outbreak at a Private Gathering in
the Faroe Islands, Infecting 21 of
33 Triple-Vaccinated Healthcare
Workers.”2 Though the article
didn’t mention measles, it evoked
the history of that virus and the
story of how a 19th-century physician discovered the secrets of
its spread.
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